BNP Paribas Financial Markets
MDLN

BNP Paribas Financial Markets’s Medline Inc MDLN Stock Holding History

BNP Paribas Financial Markets’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.4M Buy
+480,327
New +$21.2M 0.01% 1114

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

BNP Paribas Financial Markets's MDLN Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Medline Inc (MDLN) in Q1 2026: 480,327 shares worth $21.4M. The stake represents 0.01% of the portfolio and ranks #1114 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • BNP Paribas Financial Markets held 480,327 shares of Medline Inc worth $21.4M as of Q1 2026.
  • Medline Inc was a new BNP Paribas Financial Markets position in Q1 2026.
  • Medline Inc made up 0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1114 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.